Robert J. Matusik
Affiliations: | Vanderbilt University, Nashville, TN |
Area:
Cell Biology, Molecular BiologyGoogle:
"Robert Matusik"Children
Sign in to add trainee| William H. Tu | grad student | 2003 | Vanderbilt |
| Nan Gao | grad student | 2004 | Vanderbilt |
| Srinivas R. Nandana | grad student | 2010 | Vanderbilt |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Jin R, Forbes CM, Miller NL, et al. (2024) Transcriptomic analysis of benign prostatic hyperplasia identifies critical pathways in prostatic overgrowth and 5-alpha reductase inhibitor resistance. The Prostate |
| Celada SI, Li G, Celada LJ, et al. (2023) Lysosome-dependent FOXA1 ubiquitination contributes to luminal lineage of advanced prostate cancer. Molecular Oncology |
| Jin R, Forbes C, Miller NL, et al. (2022) Glucocorticoids are induced while dihydrotestosterone levels are suppressed in 5-alpha reductase inhibitor treated human benign prostate hyperplasia patients. The Prostate |
| Ochieng J, Korolkova OY, Li G, et al. (2022) Fetuin-A Promotes 3-Dimensional Growth in LNCaP Prostate Cancer Cells by Sequestering Extracellular Vesicles to Their Surfaces to Act as Signaling Platforms. International Journal of Molecular Sciences. 23 |
| Kanagasabai T, Li G, Shen TH, et al. (2021) MicroRNA-21 deficiency suppresses prostate cancer progression through downregulation of the IRS1-SREBP-1 signaling pathway. Cancer Letters |
| Kohrt SE, Awadallah WN, Phillips RA, et al. (2020) Identification of genes required for enzalutamide resistance in castration-resistant prostate cancer cells in vitro. Molecular Cancer Therapeutics |
| Li G, Kanagasabai T, Lu W, et al. (2020) KDM5B is essential for the hyper-activation of PI3K/AKT signaling in prostate tumorigenesis. Cancer Research |
| Popovics P, Awadallah WN, Kohrt SE, et al. (2020) Prostatic osteopontin expression is associated with symptomatic benign prostatic hyperplasia. The Prostate |
| Popovics* P, Awadallah WN, Kohrt S, et al. (2020) MP06-06 INCREASED EXPRESSION OF OSTEOPONTIN IN THE PROSTATE IS ASSOCIATED WITH THE CLINICAL PROGRESSION OF BPH The Journal of Urology. 203: e53 |
| Connelly ZM, Yang S, Khater N, et al. (2019) Abstract 59: The pioneer transcription factor FOXA2 regulates integrin alpha 1 expression controlling prostate cancer bone colonization Cancer Research. 79: 59-59 |